In September, KLAS Research and Bain & Company co-published our third report, Healthcare IT Spending 2024: Innovation, Integration, and AI. Our goal is to understand the market dynamics of IT spending; this year, we…
Continue Reading
Three-quarters of the nation’s healthcare providers and payers say they have increased their IT spending over the past year, according to a report released Tuesday by Bain & Company and KLAS Research.
The report predicted…
Continue Reading
AI generated summary:00:00 – IntroductionThe episode opens with an introduction to Mehdi, a healthcare consultant, and the key topics to be discussed, including the role of consultants in healthcare and the challenges they face.00:02…
Continue Reading
Bain & Company recently released study findings looking at how patients perceive generative AI in healthcare. Long story short is that patients are more comfortable with AI tools taking notes during office visits or…
Continue Reading
What You Should Know:
– New research from Bain & Company has revealed an intriguing trend in the healthcare industry: U.S. patients are more comfortable with generative artificial intelligence (AI) analyzing their radiology scans and…
Continue Reading
Medical technology company Imperative Care announced it initially closed an oversubscribed Series E financing round led by Ally Bridge Group. The company says additional closings of the round could bring its Series E up…
Continue Reading
The momentum of value-based care is poised to accelerate. The Centers for Medicare and Medicaid Services has outlined an ambitious objective: to transition all traditional Medicare beneficiaries into a VBC arrangement by 2030 –…
Continue Reading
Jay Ackerman, CEO, Reveleer
The momentum of value-based care (VBC) is poised to accelerate. The Centers for Medicare and Medicaid Services (CMS) has outlined an ambitious objective: to transition all traditional Medicare beneficiaries into a…
Continue Reading
The health technology segment in India, which comprises about 10,000 startups, is projected to triple in value by 2028 as investors shift their focus towards businesses that can withstand economic disruptions.A new report by…
Continue Reading
What You Should Know:
– Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was…
Continue Reading
